Similarly, a study (15) highlighted how targeting the PI3K-mTOR pathway, inconjunction with MMP2/9, can prevent migration in TNBC, illustrating the relevanceof the PI3K-AKT signaling axis in controlling tumor migration and invasion. This evidence concerns the gene AKT1 and neoplasm.